IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 90 filers reported holding IRADIMED CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $376,657 | +57.0% | 8,489 | +69.0% | 0.00% | – |
| Q2 2023 | $239,846 | -26.6% | 5,024 | -39.5% | 0.00% | – |
| Q1 2023 | $326,880 | +131.0% | 8,307 | +66.1% | 0.00% | – |
| Q4 2022 | $141,479 | +128.2% | 5,001 | +142.9% | 0.00% | – |
| Q3 2022 | $62,000 | -72.6% | 2,059 | -69.0% | 0.00% | – |
| Q2 2022 | $226,000 | +39.5% | 6,651 | +84.5% | 0.00% | – |
| Q1 2022 | $162,000 | -65.3% | 3,605 | -64.4% | 0.00% | – |
| Q4 2021 | $467,000 | +10.4% | 10,124 | -19.8% | 0.00% | – |
| Q3 2021 | $423,000 | +33.4% | 12,626 | +17.3% | 0.00% | – |
| Q2 2021 | $317,000 | -13.2% | 10,760 | -24.1% | 0.00% | – |
| Q1 2021 | $365,000 | +12.0% | 14,168 | -1.1% | 0.00% | – |
| Q4 2020 | $326,000 | +15.2% | 14,327 | +8.2% | 0.00% | – |
| Q3 2020 | $283,000 | -10.7% | 13,236 | -3.2% | 0.00% | – |
| Q2 2020 | $317,000 | +77.1% | 13,673 | +63.3% | 0.00% | – |
| Q1 2020 | $179,000 | -11.4% | 8,372 | -3.2% | 0.00% | – |
| Q4 2019 | $202,000 | -60.4% | 8,652 | -64.4% | 0.00% | – |
| Q3 2019 | $510,000 | +49.6% | 24,270 | +45.7% | 0.00% | – |
| Q2 2019 | $341,000 | -30.4% | 16,663 | -4.7% | 0.00% | – |
| Q1 2019 | $490,000 | +2.7% | 17,478 | -10.5% | 0.00% | – |
| Q4 2018 | $477,000 | -18.0% | 19,532 | +24.8% | 0.00% | – |
| Q3 2018 | $582,000 | +89.6% | 15,650 | +5.8% | 0.00% | – |
| Q2 2018 | $307,000 | +5016.7% | 14,793 | +3722.5% | 0.00% | – |
| Q1 2018 | $6,000 | -57.1% | 387 | -76.4% | 0.00% | – |
| Q2 2017 | $14,000 | -6.7% | 1,637 | -2.8% | 0.00% | – |
| Q1 2017 | $15,000 | +150.0% | 1,684 | +203.4% | 0.00% | – |
| Q4 2016 | $6,000 | -64.7% | 555 | -46.0% | 0.00% | – |
| Q3 2016 | $17,000 | -80.2% | 1,028 | -74.0% | 0.00% | – |
| Q2 2016 | $86,000 | -43.4% | 3,959 | -26.9% | 0.00% | – |
| Q4 2015 | $152,000 | +36.9% | 5,414 | +18.4% | 0.00% | – |
| Q3 2015 | $111,000 | +54.2% | 4,573 | +48.5% | 0.00% | – |
| Q2 2015 | $72,000 | +56.5% | 3,079 | +2.6% | 0.00% | – |
| Q1 2015 | $46,000 | +17.9% | 3,000 | 0.0% | 0.00% | – |
| Q4 2014 | $39,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |